Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Sica

Showing results (1-10 of 117) with videos related to

Pageof 12
Sort By:
Congestive Heart Failure (Greenwich, Conn.)|February 6, 2002
Pharmacotherapy in congestive heart failure: angiotensin II and thirst: therapeutic considerationsD A Sica
Journal of Clinical Hypertension (Greenwich, Conn.)|October 6, 2001
Current concepts of pharmacotherapy in hypertension: combination calcium channel blocker therapy in the treatment of hypertensionD A Sica
The American Journal of Cardiology|October 10, 2001
Dosage considerations with perindopril for systemic hypertensionD A Sica
Journal of Cardiovascular Pharmacology|January 1, 1992
Kinetics of angiotensin-converting enzyme inhibitors in renal failureD A Sica
Congestive Heart Failure (Greenwich, Conn.)|May 25, 2002
Pharmacotherapy in congestive heart failure: Vasopeptidase inhibition and its role in congestive heart failureD A Sica
Congestive Heart Failure (Greenwich, Conn.)|February 8, 2002
Pharmacotherapy in congestive heart failure. Prematurely terminated clinical trials and their application to cardiovascular medicineD A Sica
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|June 30, 2005
Novel combinations in the treatment of hypertensionD A Sica
Pharmacotherapy|April 23, 1999
Review of eprosartan: a new angiotensin II receptor antagonist. SummaryD A Sica
Drugs|July 1, 1994
Fixed-dose combination antihypertensive drugs. Do they have a role in rational therapy?D A Sica
Congestive Heart Failure (Greenwich, Conn.)|August 22, 2002
Pharmacotherapy in congestive heart failure: Cardiopulmonary effects of ophthalmically administered beta-blockersD A Sica
Pageof 12

Showing results (1-10 of 117) with videos related to

Sort By:
Pageof 12
Congestive Heart Failure (Greenwich, Conn.)|February 6, 2002
Pharmacotherapy in congestive heart failure: angiotensin II and thirst: therapeutic considerationsD A Sica
Journal of Clinical Hypertension (Greenwich, Conn.)|October 6, 2001
Current concepts of pharmacotherapy in hypertension: combination calcium channel blocker therapy in the treatment of hypertensionD A Sica
The American Journal of Cardiology|October 10, 2001
Dosage considerations with perindopril for systemic hypertensionD A Sica
Journal of Cardiovascular Pharmacology|January 1, 1992
Kinetics of angiotensin-converting enzyme inhibitors in renal failureD A Sica
Congestive Heart Failure (Greenwich, Conn.)|May 25, 2002
Pharmacotherapy in congestive heart failure: Vasopeptidase inhibition and its role in congestive heart failureD A Sica
Congestive Heart Failure (Greenwich, Conn.)|February 8, 2002
Pharmacotherapy in congestive heart failure. Prematurely terminated clinical trials and their application to cardiovascular medicineD A Sica
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|June 30, 2005
Novel combinations in the treatment of hypertensionD A Sica
Pharmacotherapy|April 23, 1999
Review of eprosartan: a new angiotensin II receptor antagonist. SummaryD A Sica
Drugs|July 1, 1994
Fixed-dose combination antihypertensive drugs. Do they have a role in rational therapy?D A Sica
Congestive Heart Failure (Greenwich, Conn.)|August 22, 2002
Pharmacotherapy in congestive heart failure: Cardiopulmonary effects of ophthalmically administered beta-blockersD A Sica
Pageof 12